Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1681-2023Class II

DePuy Mitek BIOKNOTLESS Rapid w/ Pan-Indicated for use in soft tissue to bone fixation in association with...

DePuy Mitek, Inc. / initiated 2023-04-13 / Open, Classified / root cause: labeling and UDI

DePuy Mitek, Inc., a Johnson & Johnson Co. began a recall of DePuy Mitek BIOKNOTLESS Rapid w/ Pan-Indicated for use in soft tissue to bone fixation in association with adequate postoperative immobilization Model Number... on . FDA classified it as Class II and gives the reason as "IFU Warning: Applying bending force and/or bending force with impaction to the BIOKNOTLESS Anchor Inserter may cause a fragment of the inserter tip to break off during use and be retained in the patient. broken...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1681-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
DePuy Mitek, Inc.
Product
DePuy Mitek BIOKNOTLESS Rapid w/ Pan-Indicated for use in soft tissue to bone fixation in association with adequate postoperative immobilization Model Number: 212723
Product code
MAI Fastener, Fixation, Biodegradable, Soft Tissue
Reason for recall
IFU Warning: Applying bending force and/or bending force with impaction to the BIOKNOTLESS Anchor Inserter may cause a fragment of the inserter tip to break off during use and be retained in the patient. broken BIOKNOTLESS Anchor inserter tip detected during surgery may require removal, potentially causing bone damage and longer surgery time
Root cause tag
labeling and UDI
FDA root cause
Use error
Action
DePuy Mitek issued Urgent Medical Device Correction (Notification) Letter on 4/13/23 via First Class Mail to US consignees. Internal and sales/distributors notified via email. International affiliates will be notified via email and will be initiated per local regulations. Letter states reason for recall, health risk and action to take: 1. Product is NOT being removed from the field and does not need to be returned. 2. Familiarize yourself with the content 2. Familiarize yourself with the content of this letter. 3. Review, complete all fields, sign, and return the attached business response form (BRF) on the last page of this letter to [email protected] within three (3) business days of receipt of this notification. IMPORTANT: Complete the BRF even if you do not have any of the subject product in your current inventory. 4. Forward this notice to any personnel in your facility who need to be informed. 5. If any of the subject products have been forwarded to another facility, contact that facility and provide them with this notice. 6. Post a copy of this notice in a visible area for awareness and keep a copy for your records. If you have any questions, please contact your local DePuy Synthes Sales Consultant. For Medical Information request, please visit our website: https://www.jnjmedicaldevices.com/mir.
Quantity in commerce
1125 units
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Canada, Switzerland, China, Czech Republic, Germany, Egypt, Spain, United Kingdom, Hong Kong, Hungary, Ireland, India, Italy, Korea, Netherlands, New Zealand, Slovakia, Thailand.
Product codes and lots
UDI-DI: 10886705002092 All lot numbers

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1681-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1677-2023Class IIOngoingVoluntary: Firm initiated
Z-1678-2023Class IIOngoingVoluntary: Firm initiated
Z-1679-2023Class IIOngoingVoluntary: Firm initiated
Z-1680-2023Class IIOngoingVoluntary: Firm initiated
Z-1681-2023Class IIOngoingVoluntary: Firm initiated